Karyopharm Therapeutics Inc. Stock Forecast
Weaker technical forecast for Karyopharm Therapeutics Inc. as stock downgraded to Strong Sell Candidate.
(Updated on Apr 26, 2024)
No changes to the price of Karyopharm Therapeutics Inc. stock on the last trading day (Friday, 26th Apr 2024). During the last trading day the stock fluctuated 5.88% from a day low at $1.02 to a day high of $1.08. The price has fallen in 7 of the last 10 days and is down by -13.11% for this period.
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.80% during the next 3 months and, with a 90% probability hold a price between $0.82 and $1.75 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
KPTI Signals & Forecast
Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". Some negative signals were issued as well, and these may have some influence on the near short-term development. The Karyopharm Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.13 and $1.33. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 06, 2024, and so far it has fallen -36.14%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Karyopharm Therapeutics Inc. stock
Karyopharm Therapeutics Inc. finds support from accumulated volume at $1.04 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0600 between high and low, or 5.88%. For the last week, the stock has had daily average volatility of 7.51%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (KPTI) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Karyopharm Therapeutics Inc. to open at $1.05, and during the day (based on 14 day Average True Range), to move between $0.93 and $1.19, which gives a possible trading interval of +/-$0.131 (+/-12.38%) up or down from last closing price. If Karyopharm Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 24.75% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.04 (1.89%) than the resistance at $1.29 (21.23%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Karyopharm Therapeutics Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.330. We will update the financials statements for Karyopharm Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 14.62% in the first trading day after earnings release.
Is Karyopharm Therapeutics Inc. stock A Buy?
The Karyopharm Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Karyopharm Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score: -5.350 Strong Sell Candidate Downgraded
Predicted Opening Price for Karyopharm Therapeutics Inc. of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $1.05 ( 0.629%) | $1.06 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for KPTI
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.11 | 5.03 % | |
| R2 | 1.09 | 2.87 % | ||
| R1 | 1.08 | 1.53 % | ||
| Current price: | 1.06 | |||
| Support | S1 | 1.03 | -2.79 % | |
| S2 | 1.02 | -4.13 % | ||
| S3 | 0.99 | -6.29 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.31 | 23.58 % | |
| R2 | 1.30 | 22.64 % | ||
| R1 | 1.29 | 21.23 % | ||
| Current price | 1.06 | |||
| Support | S1 | 1.04 | -1.89% | |
| S2 | 0.91 | -14.62% | ||
| S3 | 0.90 | -15.07% |
FAQ
Click here for our free guide on how to buy Karyopharm Therapeutics Inc. Stock.
